In The Cancer Genome Atlas (TCGA) LGG–GBM and Chinese Glioma Genome Atlas (CGGA) 325 datasets, patients with low CDH6 expression showed a significantly longer overall survival than those with high CDH6 expression (p < 0.0001). The gene discussed is CDH6; the disease is glioblastoma.